Percutaneous transluminal angioplasty (PCTA) is a surgical procedure to treat heart disease. It involves inserting a small balloon into the arteries to manage blockages or restore blood flow.

Among patients with type 2 diabetes and peripheral artery disease or foot ulcers, the use of semaglutide is linked to a ...

Standard percutaneous transluminal angioplasty is the current recommended treatment for dysfunctional hemodialysis fistulas, yet long-term outcomes of this treatment are poor. Drug-coated balloons ...

Evidence-based recommendations on percutaneous transluminal renal sympathetic denervation for resistant hypertension. This involves inserting a device through the skin (percutaneous) into an artery in ...

The global percutaneous transluminal angioplasty (PTA) balloons market was valued at approximately US$ 2.1 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 5.4%, ...

Atherosclerotic disease in the femoral and popliteal (femoropopliteal) arteries compromises perfusion to the legs and feet. Although treatment with percutaneous transluminal angioplasty is ...

TCT 317: Twelve-Month Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System Following Percutaneous Transluminal Angioplasty of Below-the-Knee Arteries in Patients With ...

Natural orifice transluminal endoscopic surgery (NOTES) is an emerging experimental alternative to conventional surgery that eliminates abdominal incisions and incision-related complications by ...

Current evidence on the safety of endoscopic transluminal pancreatic necrosectomy shows that there are serious but well‑recognised complications. Evidence on efficacy is adequate to support the use of ...

Teleflex announced its percutaneous transluminal coronary angioplasty perfusion balloon catheter has received FDA 510(k) clearance for balloon dilatation of coronary artery or coronary bypass ...